INTS
Intensity Therapeutics, Inc.
Set alert
- YTD
- -66.83%
- 1 year
- -89.70%
- Open
- 3.40
- Prev close
- 3.34
- Mkt cap
- 11.10M
- Vol
- 16.12K
- Avg vol
- 25.19K
- EPS
- -3.89
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.21
- High
- 3.46
- Forward P/E
- -1.66
- Beta
- 0.00
- Short ratio
- 3.05
- Inst. own
- 12.49%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 2.90
- 200-d avg
- 4.10
- 1y target
- 10.00
Discussion (4)
Sign in to join the discussion
Who’s an idiot now?! It was so obvious that this study was based on weak fundamentals and unsupported data‼️ bulls, no worries, there’s always another game
Loading up this dip, ez $$$
VICKY HANUKA INTS 2 years ago #3Benchmark Reiterates Speculative Buy on Intensity Therapeutics, Maintains $12 Price Target
Benzinga
·
08/24 08:52
1min
Intensity Therapeutics(INTS.US)
10.091
+152.28%
Benchmark analyst Robert Wasserman reiterates Intensity Therapeutics (NASDAQ:INTS) with a Speculative Buy and maintains $12 price target.
Disclaimer: This content is for informational and educational purposes only and does not constitute
VICKY HANUKA INTS 2 years ago #4Benchmark Reiterates Speculative Buy on Intensity Therapeutics, Maintains $12 Price Target
Benzinga
·
08/24 08:52
1min
Intensity Therapeutics(INTS.US)
10.091
+152.28%
Benchmark analyst Robert Wasserman reiterates Intensity Therapeutics (NASDAQ:INTS) with a Speculative Buy and maintains $12 price target.
Disclaimer: This content is for informational and educational purposes only and does not constitute